In a bid to expand access to the Pfizer (PFE) Covid-19 pill, an advocacy group is trying to create a path for generic manufacturers to sell the treatment in the Dominican Republic, which was excluded from a licensing deal the drug maker reached for its medicine to become available in mostly poor countries.
The effort by Knowledge Ecology International involves a two-pronged approach that could not only broaden availability of the Pfizer pill, but also pressure the Biden administration to take yet another step toward ensuring low- and middle-income nations have access to Covid-19 medical products. For these reasons, the initiative is likely to be closely watched.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
